Representatives from Freeman Technology will demonstrate the FT4 powder tester's capabilities at Drug Delivery to the Lungs 20 (DDL20), to take place from 9 to 11 December 2009 in Edinburgh, Scotland.
Representatives from Freeman will discuss how the FT4 universal powder tester is providing new insight into dry powder inhaler (DPI) performance.
Collaborative posters from a number of institutions will showcase the latest work.
Recent research from the University of Bath has drawn attention to the unique ability of the FT4 to sensitively characterise the response of DPI formulations to air.
A direct correlation between fine-particle fraction and aeration energy confirms the importance of this aspect of behaviour for drug delivery.
The research group involved is using this data to study the impact of lactose fines on dispersion behaviour and to understand in greater detail the mechanisms that control drug delivery.
The FT4 is a universal powder tester used throughout the pharmaceutical industry to gain insight into all aspects of powder processing.
It combines dynamic, shear and bulk property measurement to deliver accurate, multi-faceted characterisation.
